SCHEMBL14070876

C=CC(O)C(CO[C@@H]1O[C@@H](CO)C(OC2OC(CO)[C@H](OC3OC(CO)[C@H](O)[C@H](OC4OC(CO)[C@H](O)[C@H](O)[C@@H]4O)[C@@H]3NC(C)=O)[C@H](O[C@]3(C(=O)ON)C[C@@H](O)C(NC(C)=O)C(C(O)C(O)CO)O3)[C@@H]2O)C(O)C1O)NC(C)=O

nearest known ligand 0.55

Predicted protein targets (top 5)

	gene	UniProt	supporting neighbours	confidence
▸	MAG	P20916	7/20	0.54

▸	SIGLEC7	Q9Y286	6/20	0.52

▸	SELE	P16581	4/20	0.50

▸	SELP	P16109	2/20	0.49

▸	SELL	P14151	1/20	0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL18430742	0.89	SIGLEC7 (0.64)	MAGSIGLEC7SELESELPSELL
SCHEMBL24495284	0.87	SIGLEC7 (0.59)	MAGSIGLEC7SELESELPSELL
SCHEMBL29380203	0.83	SIGLEC7 (0.57)	MAGSIGLEC7SELESELPSELL
SCHEMBL12313946	0.83	SIGLEC7 (0.57)	MAGSIGLEC7SELESELPSELL
SCHEMBL19427378	0.83	SIGLEC7 (0.63)	MAGSIGLEC7SELESELPSELL
SCHEMBL24495283	0.82	SIGLEC7 (0.59)	MAGSIGLEC7SELESELPSELL
SCHEMBL29699102	0.82	SIGLEC7 (0.57)	MAGSIGLEC7SELESELPSELL
SCHEMBL30653953	0.81	SELP (0.67)	MAGSIGLEC7SELESELPSELL
SCHEMBL29532946	0.81	SELP (0.67)	MAGSIGLEC7SELESELPSELL
SCHEMBL195718	0.81	SIGLEC7 (0.57)	MAGSIGLEC7SELESELPSELL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20080213349-A1	Liposome Complexes Containing Pharmaceutical Agents and Methods	MEDTRONIC, INC.	2008-09-04	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20080213349-A1	Liposome Complexes Containing Pharmaceutical Agents and Methods	NEU1, SIGLEC7, LIPA	MAG 618/4885SIGLEC7 2/4885SELE 41/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.